Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.970
+0.150 (8.24%)
At close: Mar 9, 2026, 4:00 PM EDT
1.999
+0.029 (1.47%)
After-hours: Mar 9, 2026, 7:22 PM EDT
Caribou Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 190 | 149 | 144 | 507 | 383 | 908 | |
| Market Cap Growth | 49.10% | 3.22% | -71.59% | 32.27% | -57.82% | - | |
| Enterprise Value | 75 | 15 | -110 | 137 | 68 | 473 | |
| Last Close Price | 1.97 | 1.59 | 1.59 | 5.73 | 6.28 | 15.09 | |
| PS Ratio | 17.06 | 13.32 | 14.41 | 14.70 | 27.66 | 94.63 | |
| PB Ratio | 1.53 | 1.22 | 0.57 | 1.38 | 1.27 | 2.34 | |
| P/TBV Ratio | 1.56 | 1.22 | 0.57 | 1.38 | 1.27 | 2.34 | |
| EV/Sales Ratio | 6.70 | 1.33 | - | 3.99 | 4.94 | 49.28 | |
| Debt / Equity Ratio | 0.22 | 0.22 | 0.11 | 0.07 | 0.09 | - | |
| Net Debt / Equity Ratio | -0.95 | -0.95 | -0.88 | -0.94 | -0.96 | -1.07 | |
| Net Debt / EBITDA Ratio | 0.89 | 0.89 | 1.37 | 3.07 | 2.76 | 6.27 | |
| Net Debt / FCF Ratio | 1.03 | 1.03 | 1.56 | 3.29 | 2.97 | 11.94 | |
| Asset Turnover | 0.05 | 0.05 | 0.03 | 0.09 | 0.03 | 0.04 | |
| Quick Ratio | 5.60 | 5.60 | 6.94 | 11.76 | 8.97 | 14.87 | |
| Current Ratio | 5.72 | 5.72 | 7.16 | 11.97 | 9.25 | 15.15 | |
| Return on Equity (ROE) | -78.97% | -78.97% | -47.99% | -30.50% | -28.87% | -32.99% | |
| Return on Assets (ROA) | -34.26% | -34.26% | -27.94% | -18.00% | -16.30% | -17.50% | |
| Return on Capital Employed (ROCE) | -89.30% | -89.30% | -58.90% | -28.70% | -30.80% | -16.10% | |
| Earnings Yield | -77.81% | -99.67% | -103.56% | -20.14% | -25.95% | -7.37% | |
| FCF Yield | -59.02% | -75.60% | -99.38% | -20.70% | -25.43% | -3.81% | |
| Buyback Yield / Dilution | -3.40% | -3.40% | -22.37% | -21.39% | -92.02% | -270.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.